4//SEC Filing
VANCE DOLLY 4
Accession 0001179110-19-011940
CIK 0001034842other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 8:11 PM ET
Size
5.4 KB
Accession
0001179110-19-011940
Insider Transaction Report
Form 4
VANCE DOLLY
SVP, Gen. Counsel, Corp. Sec.
Transactions
- Award
Employee Stock Option (right to buy)
2019-11-18+75,000→ 75,000 totalExercise: $4.49Exp: 2028-01-24→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The reporting person was granted a performance based option to purchase 75,000 shares of common stock on January 24, 2018. Thus,the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001237676
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 8:11 PM ET
- Size
- 5.4 KB